When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ACOR - Acorda Therapeutics Non-GAAP EPS of -$1.66 revenue of $22.53M
Acorda Therapeutics Inc.
Acorda Therapeutics press release (NASDAQ:ACOR): Q1 Non-GAAP EPS of -$1.66. Revenue of $22.53M (-21.9% Y/Y). INBRIJA (levodopa inhalation powder) Q1 2022 net revenue of $3.7 million; 26% decrease from Q1 2021 AMPYRA (dalfampridine) Q1 2022 net revenue of $14.9 million; 27% decrease from Q1 2021 2022 AMPYRA net sales guidance reiterated at $68-$78 million